(Q35000511)

5 August 2017

1 reference

title

Folate receptor-targeted liposomes as vectors for therapeutic agents (English)

1 reference

5 August 2017

1 reference

Michael A Gosselin

1

1 reference

5 August 2017

Robert J Lee

series ordinal

2

1 reference

5 August 2017

publication date

1 January 2002

1 reference

Biotechnology Annual Review

5 August 2017

published in

1 reference

5 August 2017

volume

8

1 reference

5 August 2017

page(s)

103-131

1 reference

Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Carrier-mediated membrane transport of folates in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

1 reference

7 January 2021

Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Folate-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Folate receptor type gamma is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: protein characterization and cell type specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Structure and regulation of a polymorphic gene encoding folate receptor type gamma/gamma'.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Complete mapping of divergent amino acids responsible for differential ligand binding of folate receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Expression levels of functional folate receptors alpha and beta are related to the number of N-glycosylated sites

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Preferred Sites of Glycosylphosphatidylinositol Modification in Folate Receptors and Constraints in the Primary Structure of the Hydrophobic Portion of the Signal

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Recognition of the carboxyl-terminal signal for GPI modification requires translocation of its hydrophobic domain across the ER membrane

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Identification of amino acid residues that determine the differential ligand specificities of folate receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

The folate receptor in central nervous system malignancies of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

High-affinity folate binding in human choroid plexus. Characterization of radioligand binding, immunoreactivity, molecular heterogeneity and hydrophobic domain of the binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

A high-affinity folate binding protein in proximal tubule cells of human kidney

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Overexpression of folate binding protein in ovarian cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Membrane folate-binding proteins are responsible for folate-protein conjugate endocytosis into cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

1 reference

7 January 2021

Caveolin, a protein component of caveolae membrane coats

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Potocytosis: Sequestration and Transport of Small Molecules by Caveolae

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Measurement of endosome pH following folate receptor-mediated endocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Sequestration of GPI-anchored proteins in caveolae triggered by cross-linking

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Insolubility and redistribution of GPI-anchored proteins at the cell surface after detergent treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Endocytosis of GPI-linked membrane folate receptor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Clustering of GPI-anchored folate receptor independent of both cross-linking and association with caveolin

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Targeted drug delivery via the folate receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

The folate receptor as a potential therapeutic anticancer target

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Folate-maytansinoids: target-selective drugs of low molecular weight

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Folate-mediated targeting of antisense oligodeoxynucleotides to ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Targeted gene delivery by tropism-modified adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Transfection of folate-polylysine DNA complexes: evidence for lysosomal delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Folate copolymer-mediated transfection of cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Liposomal doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Phase I study of liposomal vincristine

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

The effects of pH and intraliposomal buffer strength on the rate of liposome content release and intracellular drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Phase II study of liposomal doxorubicin in patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Phase II study of pegylated liposomal doxorubicin: inactive in recurrent small-cell lung cancer. A Hellenic Cooperative Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluorouracil as first-line therapy in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

pH-sensitive, plasma-stable liposomes with relatively prolonged residence in circulation

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Synthesis and characterization of N-acylated, pH-sensitive 'caged' aminophospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

pH-dependent bilayer destabilization by an amphipathic peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Liposome targeting to tumors using vitamin and growth factor receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Recent advances in liposome technologies and their applications for systemic gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Improved cationic lipid formulations for in vivo gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Cationic lipid-based gene delivery systems: pharmaceutical perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Potentiation of cationic liposome-mediated gene delivery by polycations

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

Anti-HER2 immunoliposomes for targeted therapy of human tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2802%2908006-7

7 January 2021

10.1016/S1387-2656(02)08006-7

Identifiers

DOI

1 reference

5 August 2017

1 reference